NASDAQ: CNTACentessa Pharmaceuticals PLC Stock Ownership - Who owns Centessa Pharmaceuticals?
Insider buying vs selling
Have Centessa Pharmaceuticals PLC insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David M. Chao | Chief Administrative Officer | 2024-03-31 | 10,385 | $11.30 | $117.35kSell |
| Iqbal J. Hussain | General Counsel | 2024-03-31 | 7,520 | $11.30 | $84.98kSell |
| Tia L. Bush | Chief Technology Quality Ofc | 2024-03-31 | 6,419 | $11.30 | $72.53kSell |
| Saurabh Saha | Chief Executive Officer | 2024-03-31 | 36,263 | $11.30 | $409.77kSell |
| Gregory M. Weinhoff | Chief Financial Officer | 2024-03-31 | 11,742 | $11.30 | $132.68kSell |
| Karen M. Anderson | Chief People Officer | 2024-03-25 | 29,995 | $11.66 | $349.62kSell |
| Karen M. Anderson | Chief People Officer | 2024-03-25 | 19,990 | $3.85 | $76.96kBuy |
| Karen M. Anderson | Chief People Officer | 2024-03-25 | 21,165 | $12.21 | $258.34kSell |
| Karen M. Anderson | Chief People Officer | 2024-03-25 | 25,010 | $4.01 | $100.29kBuy |
| Iqbal J. Hussain | General Counsel | 2024-02-01 | 7,885 | $8.19 | $64.58kSell |
CNTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CNTA insiders and whales buy or sell their stock.
CNTA Shareholders
What type of owners hold Centessa Pharmaceuticals PLC stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Medicxi Ventures Management Jersey Ltd | 19.90% | 19,963,157 | $220.19M | Institution |
| General Atlantic LP | 9.65% | 9,681,818 | $106.79M | Institution |
| Gap Bermuda Ltd | 9.65% | 9,681,818 | $106.79M | Insider |
| Bvf Inc | 8.75% | 8,774,570 | $96.78M | Institution |
| Ecor1 Capital LLC | 5.60% | 5,618,779 | $61.98M | Institution |
| Vida Ventures Advisors LLC | 3.92% | 3,931,818 | $43.37M | Institution |
| Adage Capital Partners GP LLC | 2.89% | 2,896,128 | $31.94M | Institution |
| Fmr LLC | 2.78% | 2,787,194 | $30.74M | Institution |
| Price T Rowe Associates Inc | 2.53% | 2,539,464 | $28.01M | Institution |
| Octagon Capital Advisors LP | 2.05% | 2,060,100 | $22.72M | Institution |
CNTA vs Biotech Stocks
Centessa Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.